LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Rating of “Hold” from Analysts

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) have received a consensus rating of “Hold” from the five research firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $8.70.

A number of research analysts have recently weighed in on the stock. William Blair restated an “outperform” rating on shares of LifeStance Health Group in a report on Friday. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a report on Monday, December 16th. Finally, Barclays upped their price target on LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th.

LifeStance Health Group Stock Down 0.5 %

LFST traded down $0.04 during midday trading on Friday, hitting $7.71. 871,111 shares of the company’s stock traded hands, compared to its average volume of 1,182,347. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market cap of $2.95 billion, a PE ratio of -29.75 and a beta of 1.28. The stock’s fifty day simple moving average is $7.79 and its 200-day simple moving average is $7.21. LifeStance Health Group has a one year low of $4.64 and a one year high of $9.00.

Institutional Investors Weigh In On LifeStance Health Group

A number of hedge funds have recently bought and sold shares of the company. Blue Trust Inc. increased its stake in shares of LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after purchasing an additional 2,122 shares during the period. LPL Financial LLC increased its position in LifeStance Health Group by 6.0% in the 4th quarter. LPL Financial LLC now owns 37,584 shares of the company’s stock worth $277,000 after buying an additional 2,127 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in LifeStance Health Group by 2.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company’s stock worth $1,023,000 after buying an additional 3,305 shares during the period. MetLife Investment Management LLC lifted its holdings in shares of LifeStance Health Group by 6.8% during the fourth quarter. MetLife Investment Management LLC now owns 85,914 shares of the company’s stock worth $633,000 after buying an additional 5,492 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of LifeStance Health Group by 31.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock valued at $169,000 after acquiring an additional 5,767 shares during the period. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.